{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:40:40Z","timestamp":1793788840025,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF). However, available studies regarding this relationship have shown inconsistent results. Therefore, in this report, we performed a comprehensive review of the literature to assess the effects of psoriasis on risk of these CVDs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A search of literature until 24 December 2021 was done in PubMed, the Cochrane Library, Web of Science, Google Scholar, and Embase. Within European and East Asian populations, meta-analyses of observational studies assessing correlations between psoriasis and various CVD risk factors were conducted. Mendelian randomization (MR) was then employed to assess the causative impact of genetic pre-disposition for psoriasis on these CVD risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results of the meta-analyses indicated that, in both the European and East Asian populations, psoriasis was significantly linked to an elevated risk in the incidence of CAD (RR\u2009=\u20091.51, 95% confidence interval (CI): 1.04\u20132.18, <jats:italic>p<\/jats:italic>\u2009=\u20090.028 and RR\u2009=\u20091.91, 95% CI: 1.62\u20132.25, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and MI (RR\u2009=\u20091.23, 95% CI: 1.04\u20131.46, <jats:italic>p<\/jats:italic>\u2009=\u20090.017 and RR\u2009=\u20092.17, 95% CI: 1.44\u20133.28, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). A positive genetic relationship of psoriasis with CAD was found in European individuals (IVW OR:1.03; 95% CI: 1.01\u20131.06, <jats:italic>p<\/jats:italic>\u2009=\u20090.005) and in East Asian individuals (IVW OR:1.18; 95% CI: 1.03\u20131.32, <jats:italic>p<\/jats:italic>\u2009=\u20090.031). We also established that psoriasis was causally linked with an elevated risk of MI (IVW OR:1.05; 95% CI: 1.01\u20131.09, <jats:italic>p<\/jats:italic>\u2009=\u20090.026) in the European population as determined using an MR approach. Moreover, our MR results were congruent with the null findings from the meta-analysis assessing associations of psoriasis with HF risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This research work provides preliminary evidence that psoriasis and CVD have a common genetic origin and that targeted psoriasis treatment might improve cardiovascular outcomes. These results not only increase our knowledge of the genetic underpinnings linking a comorbidity of psoriasis with CVD but also suggests a novel approach for CVD prevention.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-022-02617-5","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T20:17:19Z","timestamp":1667333839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Psoriasis and cardiovascular disease risk in European and East Asian populations: evidence from meta-analysis and Mendelian randomization analysis"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9693-1082","authenticated-orcid":false,"given":"Liming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"2617_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1089\/dna.2013.2252","volume":"33","author":"M Qi","year":"2014","unstructured":"Qi M, Huang X, Zhou L, Zhang J. Four polymorphisms of VEGF (+405C>G, -460T>C, -2578C>A, and-1154G>A) in susceptibility to psoriasis: a meta-analysis. DNA Cell Biol. 2014;33:234\u201344.","journal-title":"DNA Cell Biol"},{"key":"2617_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/1346-8138.15052","volume":"46","author":"KJ Jung","year":"2019","unstructured":"Jung KJ, Kim TG, Lee JW, Lee M, Oh J, Lee SE, et al. Increased risk of atherosclerotic cardiovascular disease among patients with psoriasis in Korea: a 15-year nationwide population-based cohort study. J Dermatol. 2019;46:859\u201366.","journal-title":"J Dermatol."},{"key":"2617_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149316","volume":"11","author":"M Shiba","year":"2016","unstructured":"Shiba M, Kato T, Funasako M, Nakane E, Miyamoto S, Izumi T, et al. Association between psoriasis vulgaris and coronary heart disease in a hospital-based population in Japan. PLoS ONE. 2016;11: e0149316.","journal-title":"PLoS ONE"},{"key":"2617_CR4","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/jid.2015.8","volume":"135","author":"M Koch","year":"2015","unstructured":"Koch M, Baurecht H, Ried JS, Rodriguez E, Schlesinger S, Volks N, Gieger C, et al. Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures. J Invest Dermatol. 2015;135:1283\u201393.","journal-title":"J Invest Dermatol"},{"key":"2617_CR5","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/jid.2015.87","volume":"135","author":"R Parisi","year":"2015","unstructured":"Parisi R, Rutter MK, Lunt M, Young HS, Symmons DPM, Griffiths CEM, Ashcroft DM, Identification and Management of Psoriasis Associated ComorbidiTy (IMPACT) project team. Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol. 2015;135:2189\u201397.","journal-title":"J Invest Dermatol."},{"key":"2617_CR6","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/jid.2013.131","volume":"133","author":"EA Dowlatshahi","year":"2013","unstructured":"Dowlatshahi EA, Kavousi M, Nijsten T, Ikram MA, Hofman A, Franco OH, Wakkee M. Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam study. J Invest Dermatol. 2013;133:2347\u201354.","journal-title":"J Invest Dermatol"},{"key":"2617_CR7","doi-asserted-by":"crossref","unstructured":"Hadi Y, Or T, Moady G, Atar S. Psoriasis and coronary heart disease\u2014not as severe as predicted. QJM. 2022;115:388\u201392.","DOI":"10.1093\/qjmed\/hcab173"},{"key":"2617_CR8","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/jid.2015.218","volume":"135","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Troxel AB, Mehta NN, Gelfand JM. Psoriasis and cardiovascular risk: strength in numbers part 3. J Invest Dermatol. 2015;135:2148\u201350.","journal-title":"J Invest Dermatol"},{"key":"2617_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1136\/jmedgenet-2019-106200","volume":"57","author":"Y Lu","year":"2020","unstructured":"Lu Y, Gentiluomo M, Lorenzo-Bermejo J, Morelli L, Obazee O, Campa D, Canzian F. Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer. J Med Genet. 2020;57:820\u20138.","journal-title":"J Med Genet"},{"key":"2617_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050177","volume":"5","author":"NA Sheehan","year":"2008","unstructured":"Sheehan NA, Didelez V, Burton PR, Tobin MD. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 2008;5: e177.","journal-title":"PLoS Med"},{"key":"2617_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2017.8981","volume":"318","author":"SC Larsson","year":"2017","unstructured":"Larsson SC, Burgess S, Micha\u00eblsson K. Association of genetic variants related to serum calcium levels with coronary artery disease and myocardial infarction. JAMA. 2017;318:371\u201380.","journal-title":"JAMA"},{"key":"2617_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103189","volume":"63","author":"T Zhang","year":"2021","unstructured":"Zhang T, Zhao JV, Schooling CM. The associations of plasma phospholipid arachidonic acid with cardiovascular diseases: a Mendelian randomization study. EBioMedicine. 2021;63: 103189.","journal-title":"EBioMedicine"},{"key":"2617_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102956","volume":"59","author":"S Yuan","year":"2020","unstructured":"Yuan S, Carter P, Bruzelius M, Vithayathil M, Kar S, Mason AM, et al. Effects of tumour necrosis factor on cardiovascular disease and cancer: a two-sample Mendelian randomization study. EBioMedicine. 2020;59: 102956.","journal-title":"EBioMedicine"},{"key":"2617_CR14","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DGPRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med."},{"key":"2617_CR15","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"GA Wells","year":"2019","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2019."},{"key":"2617_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000041","volume":"4","author":"Y Liu","year":"2008","unstructured":"Liu Y, Helms C, Liao W, Zaba LC, Duan S, Gardner J, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008;4: e1000041.","journal-title":"PLoS Genet"},{"key":"2617_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41:199\u2013204.","journal-title":"Nat Genet"},{"key":"2617_CR18","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ng.694","volume":"42","author":"A Strange","year":"2010","unstructured":"Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2, Strange A, Capon F, Spencer CC, Knight J, Weale ME, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet. 2010;42:985\u201390.","journal-title":"Nat Genet."},{"key":"2617_CR19","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/ng.693","volume":"42","author":"PE Stuart","year":"2010","unstructured":"Stuart PE, Nair RP, Ellinghaus E, Ding J, Tejasvi T, Gudjonsson JE, et al. Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet. 2010;42:1000\u20134.","journal-title":"Nat Genet"},{"key":"2617_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ng.689","volume":"42","author":"E Ellinghaus","year":"2010","unstructured":"Ellinghaus E, Ellinghaus D, Stuart PE, Nair RP, Debrus S, Raelson JV, et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet. 2010;42:991\u20135.","journal-title":"Nat Genet."},{"key":"2617_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ajhg.2014.12.004","volume":"96","author":"H Baurecht","year":"2015","unstructured":"Baurecht H, Hotze M, Brand S, B\u00fcning C, Cormican P, Corvin A, et al. Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms. Am J Hum Genet. 2015;96:104\u201320.","journal-title":"Am J Hum Genet"},{"key":"2617_CR22","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.1038\/ncomms7916","volume":"6","author":"X Yin","year":"2015","unstructured":"Yin X, Low HQ, Wang L, Li Y, Ellinghaus E, Han J, et al. Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat Commun. 2015;6:6916.","journal-title":"Nat Commun"},{"key":"2617_CR23","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1038\/ncomms8001","volume":"6","author":"LC Tsoi","year":"2015","unstructured":"Tsoi LC, Spain SL, Ellinghaus E, Stuart PE, Capon F, Knight J, et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nat Commun. 2015;6:7001.","journal-title":"Nat Commun"},{"key":"2617_CR24","doi-asserted-by":"publisher","first-page":"15382","DOI":"10.1038\/ncomms15382","volume":"8","author":"LC Tsoi","year":"2017","unstructured":"Tsoi LC, Stuart PE, Tian C, Gudjonsson JE, Das S, Zawistowski M, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat Commun. 2017;8:15382.","journal-title":"Nat Commun"},{"key":"2617_CR25","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ng.2467","volume":"44","author":"LC Tsoi","year":"2012","unstructured":"Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet. 2012;44:1341\u20138.","journal-title":"Nat Genet"},{"key":"2617_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/ng.310","volume":"41","author":"XJ Zhang","year":"2009","unstructured":"Zhang XJ, Huang W, Yang S, Sun LD, Zhang FY, Zhu QX, et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet. 2009;41:205\u201310.","journal-title":"Nat Genet"},{"key":"2617_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jid.2017.10.001","volume":"138","author":"J Hirata","year":"2018","unstructured":"Hirata J, Hirota T, Ozeki T, Kanai M, Sudo T, Tanaka T, et al. Variants at HLA-A, HLA-C, and HLA-DQB1 confer risk of psoriasis vulgaris in Japanese. J Invest Dermatol. 2018;138:542\u20138.","journal-title":"J Invest Dermatol"},{"key":"2617_CR28","doi-asserted-by":"publisher","first-page":"6793","DOI":"10.1038\/ncomms7793","volume":"6","author":"X Zuo","year":"2015","unstructured":"Zuo X, Sun L, Yin X, Gao J, Sheng Y, Xu J, et al. Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis. Nat Commun. 2015;6:6793.","journal-title":"Nat Commun"},{"key":"2617_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jid.2019.07.692","volume":"140","author":"C Yang","year":"2020","unstructured":"Yang C, Chen M, Huang H, Li X, Qian D, Hong X, et al. Exome-wide rare loss-of-function variant enrichment study of 21,347 Han Chinese individuals identifies four susceptibility genes for psoriasis. J Invest Dermatol. 2020;140:799-805.e1.","journal-title":"J Invest Dermatol"},{"key":"2617_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","volume":"122","author":"P van der Harst","year":"2018","unstructured":"van der Harst P, Verweij N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ Res. 2018;122:433\u201343.","journal-title":"Circ Res"},{"key":"2617_CR31","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","volume":"374","author":"NG Masca","year":"2016","unstructured":"Masca NG, Erdmann J, Ferrario PG, K\u00f6nig IR, Weeke PE, Webb TR, Auer PL, et al. Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease\/. N Engl J Med. 2016;374:1134\u201344.","journal-title":"N Engl J Med"},{"key":"2617_CR32","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2016.11.056","volume":"69","author":"TR Webb","year":"2017","unstructured":"Webb TR, Erdmann J, Stirrups KE, Stitziel NO, Masca NG, et al. Systematic evaluation of pleiotropy identifies 6 further loci associated with coronary artery disease. J Am Coll Cardiol. 2017;69:823\u201336.","journal-title":"J Am Coll Cardiol"},{"key":"2617_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","volume":"11","author":"S Shah","year":"2020","unstructured":"Shah S, Henry A, Roselli C, Lin H, Sveinbj\u00f6rnsson G, Fatemifar G, Hedman \u00c5K, et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun. 2020;11:163.","journal-title":"Nat Commun"},{"key":"2617_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.119.002670","volume":"13","author":"H Matsunaga","year":"2020","unstructured":"Matsunaga H, Ito K, Akiyama M, Takahashi A, Koyama S, Nomura S, et al. Transethnic meta-analysis of genome-wide association studies identifies three new loci and characterizes population-specific differences for coronary artery disease. Circ Genom Precis Med. 2020;13: e002670.","journal-title":"Circ Genom Precis Med"},{"key":"2617_CR35","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53:1415\u201324.","journal-title":"Nat Genet"},{"key":"2617_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","volume":"29","author":"DM Sommer","year":"2006","unstructured":"Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;29:321\u20138.","journal-title":"Arch Dermatol Res"},{"key":"2617_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2133.2006.07562.x","volume":"156","author":"RJ Ludwig","year":"2007","unstructured":"Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, Thaci D, et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol. 2007;156:271\u20136.","journal-title":"Br J Dermatol"},{"key":"2617_CR38","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.amjmed.2015.05.041","volume":"128","author":"KF Hjuler","year":"2015","unstructured":"Hjuler KF, B\u00f6ttcher M, Vestergaard C, Deleuran M, Raaby L, B\u00f8tker HE, et al. Increased prevalence of coronary artery disease in severe psoriasis and severe atopic dermatitis. Am J Med. 2015;128:1325-34.e2.","journal-title":"Am J Med"},{"key":"2617_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ad.2014.08.002","volume":"106","author":"L Mahiques-Santos","year":"2015","unstructured":"Mahiques-Santos L, Soriano-Navarro CJ, Perez-Pastor G, Tomas-Cabedo G, Pitarch-Bort G, Valcuende-Cavero F. Psoriasis and ischemic coronary artery disease. Actas Dermosifiliogr. 2015;106:112\u20136.","journal-title":"Actas Dermosifiliogr"},{"key":"2617_CR40","first-page":"627","volume":"45","author":"C Yan","year":"2012","unstructured":"Yan C, Xiaomei C, Xi D, Min Z. Evaluation of coronary heart disease risks in patients with psoriasis. Chin J Dermatol. 2012;45:627\u201330.","journal-title":"Chin J Dermatol."},{"key":"2617_CR41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/joim.13311","volume":"290","author":"AB Tinggaard","year":"2021","unstructured":"Tinggaard AB, Hjuler KF, Andersen IT, Winther S, Iversen L, B\u00f8ttcher M. Prevalence and severity of coronary artery disease linked to prognosis in psoriasis and psoriatic arthritis patients: a multi-centre cohort study. J Intern Med. 2021;290:693\u2013703.","journal-title":"J Intern Med"},{"key":"2617_CR42","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1365-2133.2011.10494.x","volume":"165","author":"YW Yang","year":"2011","unstructured":"Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol. 2011;165:1037\u201343.","journal-title":"Br J Dermatol"},{"key":"2617_CR43","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/jid.2009.321","volume":"130","author":"M Wakkee","year":"2010","unstructured":"Wakkee M, Herings RM, Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol. 2010;130:962\u20137.","journal-title":"J Invest Dermatol"},{"key":"2617_CR44","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/j.1468-3083.2009.03318.x","volume":"23","author":"J Xiao","year":"2009","unstructured":"Xiao J, Chen LH, Tu YT, Deng XH, Tao J. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol. 2009;23:1311\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2617_CR45","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1365-2133.2008.09020.x","volume":"160","author":"YB Brauchli","year":"2009","unstructured":"Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol. 2009;160:1048\u201356.","journal-title":"Br J Dermatol"},{"key":"2617_CR46","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1468-3083.2009.03537.x","volume":"24","author":"J Schmitt","year":"2010","unstructured":"Schmitt J, Ford DE. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol. 2010;24:885\u201392.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2617_CR47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jaad.2010.01.050","volume":"64","author":"HW Lin","year":"2011","unstructured":"Lin HW, Wang KH, Lin HC, Lin HC. Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan. J Am Acad Dermatol. 2011;64:495\u2013501.","journal-title":"J Am Acad Dermatol"},{"key":"2617_CR48","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","volume":"149","author":"H Yeung","year":"2013","unstructured":"Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013;149:1173\u20139.","journal-title":"JAMA Dermatol"},{"key":"2617_CR49","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jjcc.2018.10.008","volume":"73","author":"M Shiba","year":"2019","unstructured":"Shiba M, Kato T, Izumi T, Miyamoto S, Nakane E, Haruna T, Inoko M. Risk of myocardial infarction in patients with psoriasis: a cross-sectional patient-population study in a Japanese hospital. J Cardiol. 2019;73:276\u20139.","journal-title":"J Cardiol"},{"key":"2617_CR50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2796.2010.02310.x","volume":"270","author":"O Ahlehoff","year":"2011","unstructured":"Ahlehoff O, Gislason GH, Charlot M, J\u00f8rgensen CH, Lindhardsen J, Olesen JB, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med. 2011;270:147\u201357.","journal-title":"J Intern Med"},{"key":"2617_CR51","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ejhf.113","volume":"16","author":"U Khalid","year":"2014","unstructured":"Khalid U, Ahlehoff O, Gislason GH, Kristensen SL, Skov L, Torp-Pedersen C, Hansen PR. Psoriasis and risk of heart failure: a nationwide cohort study. Eur J Heart Fail. 2014;16:743\u20138.","journal-title":"Eur J Heart Fail"},{"key":"2617_CR52","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1089\/cmb.2019.0180","volume":"27","author":"G Zhang","year":"2020","unstructured":"Zhang G, Li J, Sun H, Yang G. Screening for the biomarkers associated with myocardial infarction by bioinformatics analysis. J Comput Biol. 2020;27:779\u201385.","journal-title":"J Comput Biol"},{"key":"2617_CR53","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/cei.12128","volume":"173","author":"H Chen","year":"2013","unstructured":"Chen H, Xia J, Zhang L, Jin X, Yang M, Li J, Zhao Y. NKG2D blockade attenuated cardiac allograft vasculopathy in a mouse model of cardiac transplantation. Clin Exp Immunol. 2013;173:544\u201352.","journal-title":"Clin Exp Immunol"},{"key":"2617_CR54","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/jhh.2017.29","volume":"31","author":"LD Ji","year":"2017","unstructured":"Ji LD, Li JY, Yao BB, Cai XB, Shen QJ, Xu J. Are genetic polymorphisms in the renin-angiotensin-aldosterone system associated with essential hypertension? Evidence from genome-wide association studies. J Hum Hypertens. 2017;31:695\u20138.","journal-title":"J Hum Hypertens"},{"key":"2617_CR55","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/HYPERTENSIONAHA.120.16589","volume":"77","author":"CA Klemens","year":"2021","unstructured":"Klemens CA, Chulkov EG, Wu J, Hye Khan MA, Levchenko V, Flister MJ, et al. Loss of ClC-6 affects vascular smooth muscle contractility and arterial stiffness via alterations to Golgi calcium stores. Hypertension. 2021;77:582\u201393.","journal-title":"Hypertension"},{"key":"2617_CR56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1128\/CVI.00163-07","volume":"15","author":"A Palikhe","year":"2008","unstructured":"Palikhe A, Lokki ML, Saikku P, Leinonen M, Paldanius M, Sepp\u00e4nen M, et al. Association of chlamydia pneumoniae infection with HLA-B*35 in patients with coronary artery disease. Clin Vaccine Immunol. 2008;15:55\u20139.","journal-title":"Clin Vaccine Immunol"},{"key":"2617_CR57","first-page":"2538769","volume":"2022","author":"W Li","year":"2022","unstructured":"Li W, Zhang Y, Wang J, Li Q, Zhao D, Tang B, Wang S, Shao H. MicroRNA-489 promotes the apoptosis of cardiac muscle cells in myocardial ischemia-reperfusion based on smart healthcare. Healthc Eng. 2022;2022:2538769.","journal-title":"Healthc Eng"},{"key":"2617_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1017\/S0266462312000086","volume":"28","author":"A Morrison","year":"2012","unstructured":"Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, et al. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 2012;28:138\u201344.","journal-title":"Int J Technol Assess Health Care"},{"key":"2617_CR59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jclinepi.2019.10.011","volume":"118","author":"B Nussbaumer-Streit","year":"2020","unstructured":"Nussbaumer-Streit B, Klerings I, Dobrescu AI, Persad E, Stevens A, Garritty C, et al. Excluding non-English publications from evidence-syntheses did not change conclusions: a meta-epidemiological study. J Clin Epidemiol. 2020;118:42\u201354.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02617-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02617-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02617-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T21:03:42Z","timestamp":1667336622000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02617-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2617"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02617-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"7 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}